Stock ONPH ONCOLOGY PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Oncology Pharma Inc.

Equities

ONPH

US68235J2015

Market Closed - OTC Markets
Other stock markets
 13:10:16 2024-06-11 EDT 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for Oncology Pharma Inc. 0.00% -99.50%
2021 NanoSmart Pharmaceuticals, Inc. announced that it has received funding from Oncology Pharma Inc. CI
2021 Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oncology Pharma : Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
PU
Oncology Pharma : Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System
PU
Oncology Pharma : Financial Statements (Unaudited) for the year ended March 31, 2022
PU
Oncology Pharma : Financial Statements for the period ended December 31, 2021
PU
Oncology Pharma : Disclosure Statement for the period ended December 31, 2021
PU
Oncology Pharma Inc :.
AQ
Oncology Pharma : Has Provided Initial Funding to NanoSmart Pharmaceuticals to Conduct Feasibility Studies for Initial Phases of IND-Enabling Activities
AQ
NanoSmart Pharmaceuticals, Inc. announced that it has received funding from Oncology Pharma Inc.
CI
Oncology Pharma : Reveals Strategic Plans for Company Growth and Focus
AQ
Oncology Pharma : Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy
AQ
Oncology Pharma, Inc. Vetting CROs to Develop Research Plan and Indications for Recently Licensed Cancer Combination Therapy
CI
Oncology Pharma : Moves to Fund Lead Drug Formulation & IND-Enabling Studies
AQ
Oncology Pharma Inc. Moves to Fund Lead Drug Formulation & IND-Enabling Studies
CI
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent
GL
Oncology Pharma Signs Worldwide Licensing Agreement with Sybleu, Inc. for Commercialization of Chemotherapeutic Agent in Combination with a Bioactive Immunostimulatory Agent
CI
Oncology Pharma : Extends Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Veterinary Oncology
AQ
Oncology Pharma Extends Licensing Agreement with Nanosmart Pharmaceuticals, Inc. for Veterinary Oncology
CI
Oncology Pharma : is Pleased to Welcome New Chairman to Its Scientific Advisory Board
AQ
Oncology Pharma Inc. Announces Henry Smith as New Chairman to Its Scientific Advisory Board
CI
Oncology Pharma : Renews Licensing Agreement With Ribera Solutions LLC for Its Connect2Med Clinical Trials Platform
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ONPH Stock
  4. News Oncology Pharma Inc.